Locally Advanced Cervical Carcinoma: Clinical Trials

17 trials for Locally Advanced Cervical Carcinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 recruiting, 3 active not recruiting, 3 unknown, 2 not yet recruiting. 7 Phase 2, 6 Phase 1, 3 Not applicable, 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 27Recruiting 3, Active not recruiting 2, Not yet recruiting 1, Unknown 1
Phase 16Recruiting 3, Active not recruiting 1, Not yet recruiting 1, Withdrawn 1
Not applicable3Recruiting 2, Unknown 1
Phase 33Active not recruiting 1, Not yet recruiting 1, Recruiting 1

Follow Locally Advanced Cervical Carcinoma: new trials by email Literature Review of Locally Advanced Cervical Carcinoma trials Research Report on Locally Advanced Cervical Carcinoma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Clinical Study of QL1706 Combined With Chemotherapy as Neoadjuvant Therapy for High-Risk Locally Advanced Cervical Cancer
standard EBRT+Brachytherapy, Cisplatin, Neoadjuvant chemoimmunotherapy - Locally Advanced Cervical Carcinoma
Phase 3Not yet recruitingFujian Cancer Hospital4862026-09-012026-05-29
A Clinical Study on the Treatment of LACC With Cadonilimab Combined With Chemotherapy Followed by CCRT
standard EBRT+Brachytherapy, Concurrent chemotherapy, Immune induction therapy - Locally Advanced Cervical Carcinoma
Phase 3RecruitingUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology3782026-04-242026-05-13
STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma
Aldesleukin, Biopsy, Biospecimen Collection - Locally Advanced Cervical Carcinoma, Locally Advanced Colorectal Carcinoma
Phase 1WithdrawnCity of Hope Medical Center2025-12-052025-12-24
Accelerated Brachytherapy Forward Chemo Radiation Therapy (ABC-RT) for Locally-advanced Cervical Cancer
Hypofractionated external beam radiation, Chemotherapy, Image-guided brachytherapy - Locally Advanced Cervical Carcinoma
Phase 1 / Phase 2RecruitingWashington University School of Medicine502025-02-112026-07-27
Gastric-type Endocervical Adenocarcinoma: a Population-based Cohort Study
surgery - Uterine Cervical Neoplasms, Surgery
CompletedSun Yat-Sen Memorial Hospital of Sun Yat-Sen University3172024-10-012025-03-26
Evaluation of Ultraaccelerated High Dose Rate Intrauterine Interventional Radiotherapy
Interventional Radiotherapy - Locally Advanced Cervical Carcinoma
RecruitingFondazione Policlinico Universitario Agostino Gemelli IRCCS1292024-05-062025-08-15
MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial
Tumor collection via biopsy, Blood collection, Diffusion basis spectrum imaging (DBSI) magnetic resonance imaging (MRI) - Locally Advanced Cervical Carcinoma, Locally Advanced Cervical Cancer
Not applicableRecruitingWashington University School of Medicine602024-01-112026-08-17
HYpofractionated Pelvic Radiotherapy for Advanced Cervical Cancers INeligible for ChemoTherapy
Hypofractionation - Locally Advanced Cervical Carcinoma
Phase 1 / Phase 2Not yet recruitingUniversity of Santo Tomas Hospital, Philippines552024-01-012023-01-31
Time-Restricted Eating Versus Nutritional Counseling for the Reduction of Radiation or Chemoradiation Tx Side Effects in Patients With Prostate, Cervical, or Rectal Cancers
Biospecimen Collection, Informational Intervention, Quality-of-Life Assessment - Localized Prostate Carcinoma, Locally Advanced Cervical Carcinoma
Phase 2Active not recruitingCity of Hope Medical Center492023-03-232026-10-20
Decision Aid for Chemotherapy in Cisplatin-Intolerant Patients With Locally Advanced Cervical Cancer
CECIL Patient Decision Aid - Locally Advanced Cervical Carcinoma
Not applicableUnknownUniversity of Santo Tomas Hospital, Philippines452023-02-202024-02-23
A Study of AK104/Placebo Combined With Chemoradiotherapy For The Treatment of Locally Advanced Cervical Cancer
AK104, EBRT, BT - Locally Advanced Cervical Carcinoma
Phase 3Active not recruitingAkeso6362022-06-212024-08-13
Autologous Heterotopic Fresh Ovarian Graft in Woman With LACC Eligible for Pelvic Radiotherapy Treatment.
Ovarian graft - Locally Advanced Cervical Carcinoma, Premature Ovarian Failure
Phase 1 / Phase 2Active not recruitingMARILIA ALBANEZI BERTOLAZZI222022-06-082025-09-05
PROTECT: On-line Adaptive Proton Therapy for Cervical Cancer
External beam radiation therapy: IMRT/VMAT, External beam radiation therapy: IMPT, Cisplatin - Uterine Cervical Neoplasms, Locally Advanced Cervical Carcinoma
Not applicableRecruitingLeiden University Medical Center302022-05-022023-10-11
Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
Cyclophosphamide, Neoantigen Peptide Vaccine, Pembrolizumab - Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8
Phase 1 / Phase 2RecruitingMayo Clinic1382022-03-312026-08-20
the Predictive Value of Immune Cell in Locally Advanced Cervical Cancer
Nab-paclitaxel/Platinum, Sintilimab - Locally Advanced Cervical Carcinoma, Concurrent Chemoradiotherapy
UnknownRenJi Hospital202022-01-012024-04-23
Concurrent Chemoradiotherapy Followed by PD-1 Inhibitor in Advanced Cervical Cancer
Albumin-Bound Paclitaxel, cisplatin, Sintilimab - Locally Advanced Cervical Carcinoma, Concurrent Chemoradiotherapy
Phase 1 / Phase 2RecruitingRenJi Hospital202022-01-012024-04-30
How To Evaluate The Efficiency And Safety Of Neoadjuvant Chemotherapy In Locally Advanced Cancer Cervix
Cis Platinum + Irinotecan - Locally Advanced Cervical Carcinoma
Phase 2UnknownAssiut University502021-04-012021-03-10

Narrower conditions

Uterine Cervical Neoplasms (8)  ·  Carcinoma, Renal Cell (2)  ·  Melanoma (2)  ·  Neoplasm Metastasis (2)  ·  Pancreatic Neoplasms (2)  ·  Carcinoma, Hepatocellular (1)  ·  Carcinoma, Lobular (1)  ·  Carcinoma, Merkel Cell (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Carcinoma, Transitional Cell (1)  ·  Carcinosarcoma (1)  ·  Colorectal Neoplasms (1)  ·  Endometrial Neoplasms (1)  ·  Lung Neoplasms (1)  ·  Primary Ovarian Insufficiency (1)

Broader conditions

Genital Diseases (10)  ·  Urogenital Diseases (10)  ·  Female Urogenital Diseases (9)  ·  Female Urogenital Diseases and Pregnancy Complications (9)  ·  Genital Diseases, Female (9)  ·  Neoplasms (9)  ·  Neoplasms by Site (9)  ·  Urogenital Neoplasms (9)  ·  Genital Neoplasms, Female (8)  ·  Uterine Cervical Diseases (8)  ·  Uterine Diseases (8)  ·  Uterine Neoplasms (8)  ·  Digestive System Diseases (4)  ·  Digestive System Neoplasms (4)  ·  Male Urogenital Diseases (4)

Interventions

Cisplatin (5)  ·  Specimen Handling (3)  ·  Biopsy (2)  ·  Brachytherapy (2)  ·  Cyclophosphamide (2)  ·  Magnetic Resonance Spectroscopy (2)  ·  sintilimab (2)  ·  130-nm albumin-bound paclitaxel (1)  ·  Albumin-Bound Paclitaxel (1)  ·  Blood Specimen Collection (1)  ·  Colony-Stimulating Factors (1)  ·  Drug Therapy (1)  ·  Immunoglobulin G (1)  ·  Immunotherapy (1)  ·  Irinotecan (1)

Sponsors

City of Hope Medical Center (2)  ·  RenJi Hospital (2)  ·  University of Santo Tomas Hospital, Philippines (2)  ·  Washington University School of Medicine (2)  ·  Akeso (1)  ·  Assiut University (1)  ·  Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1)  ·  Fujian Cancer Hospital (1)  ·  Leiden University Medical Center (1)  ·  MARILIA ALBANEZI BERTOLAZZI (1)  ·  Mayo Clinic (1)  ·  Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (1)  ·  Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1)

Countries

China (6)  ·  United States (4)  ·  Brazil (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Philippines (1)

Top investigators

Warren Bacorro, MD (2)  ·  Guiling Li, PHD (1)  ·  Huaiwu Lu (1)  ·  Jihong Liu, Ph.D (1)  ·  Michael Waters, M.D., Ph.D. (1)  ·  Stephanie M. de Boer, MD, PhD (1)  ·  Stephanie Markovina, M.D. (1)  ·  Vincent Chung (1)  ·  Yang Xiang, MD (1)  ·  Yanyan Lou, MD, PhD (1)  ·  Yun R Li (1)

Results publications

PMID 37677124

NIH funding

P30CA033572 (2), R37CA287204 (1), U54CA274318 (1)